Startseite Measurement of mycophenolic acid in plasma or serum by a commercial enzyme inhibition technique in comparison with a high performance liquid chromatography method
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Measurement of mycophenolic acid in plasma or serum by a commercial enzyme inhibition technique in comparison with a high performance liquid chromatography method

  • Dustin R. Bunch und Sihe Wang
Veröffentlicht/Copyright: 8. Juli 2008
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Mycophenolic acid (MPA) is the primary active metabolite of the immunosuppressant mycophenolate mofetil. High performance liquid chromatography (HPLC) is commonly used for therapeutic drug monitoring (TDM) of MPA but requires batched runs. Recently, an enzyme inhibition assay (EIA) was approved for MPA TDM on random-access platforms using either serum or EDTA plasma. We evaluated the EIA on a Roche Integra 400 using serum and heparinized plasma in comparison with a validated HPLC method.

Methods: Heparinized plasma from leftover clinical samples on which MPA was ordered along with paired serum samples, drawn at the same time for other clinical tests, were used for the method comparison.

Results: The EIA was linear from 3.1 to 44.0 μmol/L with an accuracy of 93.9%–107.1%. The intra- and inter-day variations were 0.5%–2.7% and 1.6%–2.1%, respectively. The limit of detection was 0.8 μmol/L and the limit of quantification was 3.1 μmol/L. The method showed a mean bias of 0.6 μmol/L (7.6%) in serum samples (3.1–34.1 μmol/L) vs. the HPLC method using paired plasma (n=229). Heparinized plasma (n=114) vs. serum showed a mean bias of –0.1 μmol/L (–1.6%) by the EIA.

Conclusions: The random-access EIA on Integra 400 is acceptable for clinical MPA TDM in either serum or heparinized plasma.

Clin Chem Lab Med 2008;46:1281–4.


Corresponding author: Sihe Wang, Section of Clinical Biochemistry, Department of Clinical Pathology, Mail Code L11, 9500 Euclid Ave, Cleveland, OH 44195, USA Phone: +1-216-445-2634, Fax: +1-216-444-4414,

Received: 2008-2-26
Accepted: 2008-4-24
Published Online: 2008-07-8
Published in Print: 2008-09-01

©2008 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Review
  2. Application of spin label electron paramagnetic resonance in the diagnosis and prognosis of cancer and sepsis
  3. Opinion Papers
  4. Local regression: a new approach for measurement system comparison analysis
  5. Accuracy in clinical chemistry – who will kiss Sleeping Beauty awake?
  6. A practical approach to instrument selection, evaluation, basic financial management and implementation in pathology and research
  7. Genetics and Molecular Diagnostics
  8. Fetal hemoglobin: assessment of glycation and acetylation status by electrospray ionization mass spectrometry
  9. Preliminary validation of real-time PCR assays for the identification of Yersinia pestis
  10. Biochemical and molecular investigation of two Korean patients with glycogen storage disease type III
  11. Are microarrays useful in the screening of ABCA4 mutations in Italian patients affected by macular degenerations?
  12. General Clinical Chemistry and Laboratory Medicine
  13. Quantification of vascular endothelial growth factor, interleukin-8, and basic fibroblast growth factor in plasma of cancer patients and healthy volunteers – comparison of ELISA and microsphere-based multiplexed immunoassay
  14. Low serum vitamin B12 is associated with recurrent pregnancy loss in Syrian women
  15. Allantoin as a marker of oxidative stress in human erythrocytes
  16. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome
  17. Measurement of mycophenolic acid in plasma or serum by a commercial enzyme inhibition technique in comparison with a high performance liquid chromatography method
  18. Use of the TLX ultracentrifuge for the isolation of different density lipoproteins and effects of freeze/thawing of human plasma before ultracentrifugation
  19. Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters
  20. Reference Values and Biological Variations
  21. Reference ranges for neuroprotein S-100B: from infants to adolescents
  22. Variability in longitudinal cerebrospinal fluid tau and phosphorylated tau measurements
  23. Reference intervals for thyreotropin and thyroid hormones for healthy adults based on the NOBIDA material and determined using a Modular E170®
  24. Influence of acute physical exercise on emerging muscular biomarkers
  25. Guidelines and Recommendations
  26. Trueness verification of actual creatinine assays in the European market demonstrates a disappointing variability that needs substantial improvement. An international study in the framework of the EC4 creatinine standardization working group
  27. Letters to the Editor
  28. What's in a name? Standardisation of HbA1c: a response
  29. Choice of sample for the analysis of circulating angiogenic cytokines
  30. Plasminogen activator inhibitor-1 (PAI-1), toll-like receptor 4 (TLR4), factor II (FII), FXIII and fibrinogen polymorphisms are not associated with the prevalence of sudden death due to ventricular fibrillation during myocardial infarction
  31. Spurious hypoglycemia caused by precipitation of a monoclonal immunoglobulin using the Modular P system glucose method
  32. Reporting growth hormone assay results in terms of one consensus recombinant standard preparation offers less than optimal reduction of between-method variation
  33. SI or non-SI units – which better match day-to-day imprecision?
  34. Results of hemolyzed samples can be useful
  35. Inter-laboratory survey of erythrocyte free protoporphyrin quantification – announcement of a pilot study
  36. Bacterial contamination positively interferes with β-glucosidase and hexosaminidase assays in white blood cell lysates
  37. Abstracts
  38. Congress of Clinical Chemistry and Laboratory Medicine. 5th Annual Conference of the German United Society of Clinical Chemistry and Laboratory Medicine (DGKL), September 21–24, 2008, Mannheim, Germany
  39. SIBioC 2008 40th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, October 28–31, 2008, Rimini, Italy
Heruntergeladen am 14.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.243/html
Button zum nach oben scrollen